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Résumé en
anglais
To direct stem cell fate, a delicate control of gene expression through small
interference RNA (siRNA) is emerging as a new and safe promising strategy. In this
way, the expression of proteins hindering neuronal commitment may be transiently
inhibited thus driving differentiation. Mesenchymal stem cells (MSC), which secrete
tissue repair factors, possess immunomodulatory properties and may differentiate
towards the neuronal lineage, are a promising cell source for cell therapy studies in
the central nervous system. To better drive their neuronal commitment the repressor
Element-1 silencing transcription (REST) factor, may be inhibited by siRNA
technology. The design of novel nanoparticles (NP) capable of safely delivering nucleic
acids is crucial in order to successfully develop this strategy. In this study we
developed and characterized two different siRNA NP. On one hand, sorbitan
monooleate (Span(®)80) based NP incorporating the cationic components poly-l-
arginine or cationized pullulan, thus allowing the association of siRNA were designed.
These NP presented a small size (205 nm) and a negative surface charge (-38 mV). On
the other hand, lipid nanocapsules (LNC) associating polymers with lipids and
allowing encapsulation of siRNA complexed with lipoplexes were also developed. Their
size was of 82 nm with a positive surface charge of +7 mV. Both NP could be frozen
with appropriate cryoprotectors. Cytotoxicity and transfection efficiency at different
siRNA doses were monitored by evaluating REST expression. An inhibition of around
60% of REST expression was observed with both NP when associating 250 ng/mL of
siRNA-REST, as recommended for commercial reagents. Span NP were less toxic for
human MSCs than LNCs, but although both NP showed a similar inhibition of REST
over time and the induction of neuronal commitment, LNC-siREST induced a higher
expression of neuronal markers. Therefore, two different tailored siRNA NP offering
great potential for human stem cell differentiation have been developed, encouraging
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